tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Yigal Nochomovitz, 84 are a HOLD (19.18%), 335 are a BUY (76.48%), 19 are a SELL (4.34%).
Analyst Yigal Nochomovitz works at CITI with a stock forecast success ratio of 50.08% fulfilled within 173.88 days on average.
Yigal Nochomovitzās has documented 863 price targets and ratings displayed on 49 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CRSP, Crispr Therapeutics AG at 18-Apr-2024.
Analyst best performing recommendations are on CMRX (CHIMERIX).
The best stock recommendation documented was for CMRX (CHIMERIX) at 12/24/2015. The price target of $19 was fulfilled within 4 days with a profit of $16.57 (46.58%) receiving and performance score of 116.46.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
13
1 years 7 months 28 days ago
1/5 (20%)
$4.7 (56.63%)
176
Hold
1 years 8 months 2 days ago
0/1 (0%)
$6.53 (25.64%)
Hold
20
1 years 8 months 2 days ago
0/4 (0%)
$14.21 (245.42%)
Buy
15.25
27
1 years 8 months 3 days ago
7/11 (63.64%)
$0.09 (0.59%)
149
Hold
15.25
30
1 years 8 months 3 days ago
1/3 (33.33%)
$0.09 (0.59%)
48
Which stock is Yigal Nochomovitz is most bullish on?
Which stock is Yigal Nochomovitz is most reserved on?
What Year was the first public recommendation made by Yigal Nochomovitz?
